Planchard D - Search Results

1

Staging of nutrition disorders in non-small-cell lung cancer patients: utility of skeletal muscle mass assessment.

Antoun S, Morel H, Souquet PJ, Surmont V, Planchard D, Bonnetain F, Foucher P, Egenod T, Krakowski I, Gaudin H, Debieuvre D. Antoun S, et al. Among authors: planchard d. J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):782-793. doi: 10.1002/jcsm.12418. Epub 2019 Apr 1. J Cachexia Sarcopenia Muscle. 2019. PMID: 30932365 Free PMC article.

2

[Towards customized therapy for non small cell lung cancer].

Planchard D, Besse B. Planchard D, et al. Bull Cancer. 2008 Oct;95(10):951-8. doi: 10.1684/bdc.2008.0719. Bull Cancer. 2008. PMID: 19004725 French.

3

Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors.

Barlési F, Balleyguier C, Besse B, Bonodeau F, Brenac F, Corneloup O, Dansin E, Ferretti G, Gaubert JY, Gervais R, Lacombe C, Loundou A, Moro-Sibilot D, Planchard D, Scherpereel A, Menu Y. Barlési F, et al. Among authors: planchard d. Ann Oncol. 2010 Aug;21(8):1682-1686. doi: 10.1093/annonc/mdp590. Epub 2010 Jan 11. Ann Oncol. 2010. PMID: 20064831 Free article.

4

[ERCC1 and lung cancer].

Planchard D, Olaussen KA, Soria JC. Planchard D, et al. Rev Mal Respir. 2010 Apr;27(4):387-94. doi: 10.1016/j.rmr.2010.03.003. Epub 2010 Mar 25. Rev Mal Respir. 2010. PMID: 20403548 Review. French.

5

[DNA repair pathways and non-small cell lung cancer: clinical perspectives].

Olaussen KA, Planchard D, Adam J, Soria JC. Olaussen KA, et al. Among authors: planchard d. Bull Cancer. 2011 Mar;98(3):305-22. doi: 10.1684/bdc.2011.1327. Bull Cancer. 2011. PMID: 21459711 Review. French.

6

[Biomarkers and targeted therapies in non-small cell lung cancer: present and future treatments].

Planchard D, Giroux Leprieur E. Planchard D, et al. Rev Pneumol Clin. 2011 Jun;67 Suppl 1:S36-40. doi: 10.1016/S0761-8417(11)70009-8. Rev Pneumol Clin. 2011. PMID: 21777766 French.

7

Bevacizumab in non-small-cell lung cancer: a review.

Planchard D. Planchard D. Expert Rev Anticancer Ther. 2011 Aug;11(8):1163-79. doi: 10.1586/era.11.80. Expert Rev Anticancer Ther. 2011. PMID: 21916570 Review.

8

Small cell lung cancer: new clinical recommendations and current status of biomarker assessment.

Planchard D, Le Péchoux C. Planchard D, et al. Eur J Cancer. 2011 Sep;47 Suppl 3:S272-83. doi: 10.1016/S0959-8049(11)70173-3. Eur J Cancer. 2011. PMID: 21943984 Review.

9

Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer.

Lecharpentier A, Vielh P, Perez-Moreno P, Planchard D, Soria JC, Farace F. Lecharpentier A, et al. Among authors: planchard d. Br J Cancer. 2011 Oct 25;105(9):1338-41. doi: 10.1038/bjc.2011.405. Epub 2011 Oct 4. Br J Cancer. 2011. PMID: 21970878 Free PMC article.

10

Phase 2 study of frontline bortezomib in patients with advanced non-small cell lung cancer.

Besse B, Planchard D, Veillard AS, Taillade L, Khayat D, Ducourtieux M, Pignon JP, Lumbroso J, Lafontaine C, Mathiot C, Soria JC. Besse B, et al. Among authors: planchard d. Lung Cancer. 2012 Apr;76(1):78-83. doi: 10.1016/j.lungcan.2011.09.006. Epub 2011 Dec 18. Lung Cancer. 2012. PMID: 22186627 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

283 results

Search Page

Filters